Статья

The Global Burden of Cancer 2013

Christina FitzmauriceDivision of Hematology, Department of Medicine, University of Washington, Seattle2Institute for Health Metrics and Evaluation, University of Washington, SeattleDaniel DickerInstitute for Health Metrics and Evaluation, University of Washington, SeattleAmanda PainInstitute for Health Metrics and Evaluation, University of Washington, SeattleHannah HamavidInstitute for Health Metrics and Evaluation, University of Washington, SeattleMaziar Moradi‐LakehInstitute for Health Metrics and Evaluation, University of Washington, Seattle3Gastrointestinal and Liver Disease Research Center, Iran University of Medical Sciences, Tehran, IranMichael F MacIntyreInstitute for Health Metrics and Evaluation, University of Washington, SeattleChristine A. AllenInstitute for Health Metrics and Evaluation, University of Washington, SeattleGillian M HansenInstitute for Health Metrics and Evaluation, University of Washington, SeattleRachel WoodbrookInstitute for Health Metrics and Evaluation, University of Washington, SeattleCharles WolfeKing’s College London, London, EnglandRandah R HamadehArabian Gulf University, Manama, BahrainAmi R. MooreUniversity of North Texas, DentonAndrea WerdeckerBradford D. GessnerAgence de Medecine Preventive, Paris, FranceBraden Te AoDepartment of Biostatistics and Epidemiology, School of Public Health and Psychosocial Studies, Auckland University of Technology, Auckland, New ZealandBrian J. McMahonLiver Disease and Hepatitis Program, Alaska Native Tribal Health Consortium, Anchorage, AlaskaChanté KarimkhaniCollege of Physicians and Surgeons, Columbia University, New York, New YorkChuanhua YuDepartment of Epidemiology and Biostatistics, School of Public Health, Wuhan University, Wuhan, ChinaGraham CookeImperial College London, London, EnglandDavid C. SchwebelDepartment of Psychology, University of Alabama at Birmingham, Birmingham, AlabamaDavid O. CarpenterInstitute for Health and the Environment, University at Albany, Rensselaer, New YorkDavid M. PereiraLaboratório de Farmacognosia, Departamento de Ciências Químicas, Faculdade de Farmácia, University do Porto, REQUIMTE/LAQV, Porto, PortugalDenis NashSchool of Public Health, Hunter College Campus, City University of New York, New YorkDhruv S KaziUniversity of California, San FranciscoDiego De LeoGriffith University, Brisbane, AustraliaDietrich PlaßFederal Environment Agency Section on Exposure Assessment and Environmental Health Indicators, Berlin, GermanyKingsley Nnanna UkwajaDepartment of Internal Medicine, Federal Teaching Hospital, Abakaliki, NigeriaGeorge D. ThurstonNelson Institute of Environmental Medicine, New York University School of Medicine, Tuxedo, New YorkKim Yun JinFaculty of Chinese Medicine, Southern University College, Johor, MalaysiaEdgar P. SimardRollins School of Public Health, Emory University, Atlanta, GeorgiaEdward J MillsUniversity of Ottawa, Ottawa, Ontario, CanadaEun‐Kee ParkDepartment of Medical Humanities and Social Medicine, Kosin University College of Medicine, Busan, South KoreaFerrán Catalá-LópezDivision of Pharmacoepidemiology and Pharmacovigilance, Spanish Medicines and Healthcare Products Agency (AEMPS), Ministry of Health, Madrid, SpainGabrielle deVeberUniversity of Toronto, Toronto, Ontario, CanadaCarolyn GotaySchool of Population and Public Health, University of British Columbia, Vancouver, British Columbia, CanadaGulfaraz KhanDepartment of Microbiology & Immunology, College of Medicine and Health Sciences, United Arab Emirates University, Al-Ain, United Arab EmiratesHung Chak HoAlbert Einstein College of Medicine, Bronx, New YorkItamar S SantosCentre for Clinical and Epidemiological Research, University of São Paulo, São Paulo, BrazilJanet L LeasherNova Southeastern University, Fort Lauderdale, FloridaJasvinder A. SinghDivision of Clinical Immunology and Rheumatology, University of Alabama at Birmingham, Birmingham, AlabamaJames LeighUniversity of Sydney, Sydney, AustraliaJost B. JonasDepartment of Ophthalmology, University of Heidelberg, Mannheim, GermanyJuan SanabriaDepartment of Surgery, Case Western Reserve University, Cleveland, Ohio38Nutrition and Preventive Medicine, Chicago Medical School at Cancer Treatment Centers of America, Rosalind Franklin University, Chicago, IllinoisJustin BeardsleyNuffield Department of Medicine, Oxford University, Ho Chi Minh City, VietnamKathryn H. JacobsenDepartment of Global and Community Health, George Mason University, Fairfax, VirginiaKen TakahashiDepartment of Environmental Epidemiology, University of Occupational and Environmental Health, Kitakyushu, JapanRichard C. FranklinCollege of Public Health, Medical and Veterinary Sciences, James Cook University, Townsville, AustraliaLuca RonfaniInstitute for Maternal and Child Health IRCCS Burlo Garofolo, Trieste, ItalyMarcella MonticoInstitute for Maternal and Child Health IRCCS Burlo Garofolo, Trieste, ItalyLuigi NaldiAzienda Ospedaliera papa Giovanni XXIII, Bergamo, ItalyMarcello TonelliUniversity of Calgary, Calgary, Alberta, CanadaJohanna M. GeleijnseDivision of Human Nutrition, Wageningen University, Wageningen, the NetherlandsMax PetzoldCentre for Applied Biostatistics, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden48School of Public Health, University of the Witwatersrand, Johannesburg, South AfricaMark G. ShrimeHarvard University, Boston, MassachusettsMustafa Z YounisJackson State University, Jackson, MississippiNaohiro YonemotoNational Center of Neurology and Psychiatry, Kodira, JapanNicholas J. K. BreitbordeUniversity of Arizona, TucsonPaul YipThe University of Hong Kong, Hong Kong, ChinaFarshad PourmalekFaculty of Medicine, University of British Columbia, Vancouver, British Columbia, CanadaPaulo A. LotufoCentre for Clinical and Epidemiological Research, University of São Paulo, São Paulo, BrazilAlireza EsteghamatiEndocrinology and Metabolism Research Center, Tehran University of Medical Sciences, Tehran, IranGraeme J. HankeySchool of Medicine and Pharmacology, University of Western Australia, School of Medicine and Pharmacology, Perth, AustraliaRaghib AliNuffield Department of Population Health, University of Oxford, Oxford, EnglandRaimundas LunevičiusDepartment of Neuropsychopharmacology, Aintree University Hospital NHS Foundation Trust, Liverpool, EnglandReza MalekzadehDigestive Disease Research Institute, Tehran University of Medical Sciences, Tehran, IranRobert P DellavalleVeterans Affairs Eastern Colorado Health Care System, Denver61Department of Dermatology, University of Colorado School of Medicine, DenverRobert WeintraubUniversity of Melbourne, Melbourne, Australia63Royal Children’s Hospital, Melbourne, AustraliaRobyn LucasNational Centre for Epidemiology and Population Health, Research School of Population Health, The Australian National University, Canberra, AustraliaRoderick J. HayInternational Foundation for Dermatology, London, EnglandDavid Rojas‐RuedaCentre of Research in Environmental Epidemiology (CREAL), Barcelona, SpainRonny WestermanUniversity of Marburg, Marburg, GermanySadaf G SepanlouDigestive Diseases Research Institute, Shariati Hospital, Tehran, IranSandra NolteCharité University Medicine Berlin, Berlin, GermanyScott B. PattenDepartment of Community Health Sciences, University of Calgary, Calgary, Alberta, CanadaScott WeichenthalAir Health Science Division, Health Canada, Ottawa, Ontario, CanadaSemaw Ferede AberaCollege of Health Sciences, Mekelle University, Mekelle, EthiopiaSeyed-Mohammad FereshtehnejadDepartment of Neurobiology Care Sciences and Society (NVS), Karolinska Institutet, Stockholm, SwedenIvy ShiueNorthumbria University, Newcastle upon Tyne, England75University of Edinburgh, Edinburgh, ScotlandTim DriscollSydney School of Public Health, University of Sydney, Sydney, AustraliaTommi VasankariUKK Institute for Health Promotion Research, Tampere, FinlandUbai AlsharifCharité–Universitätsmedizin Berlin, Berlin, GermanyVafa Rahimi‐MovagharSina Trauma and Surgery Research Center, Tehran University of Medical Sciences, Tehran, IranVasily VlassovNational Research University Higher School of Economics, Moscow, RussiaWagner MarcenesBarts and The London School of Medicine and Dentistry, University of London, London, EnglandWubegzier MekonnenSchool of Public Health, Addis Ababa University, Addis Ababa, EthiopiaYohannes Adama MelakuCollege of Health Sciences, School of Public Health, Mekelle University, Mekelle, EthiopiaYuichiro YanoDepartment of Preventive Medicine, Northwestern University, Chicago, IllinoisAl ArtamanIsmael Campos‐NonatoHarvard University, Boston, MassachusettsJennifer H MacLachlanVictorian Infectious Diseases Reference Laboratory (VIDRL), The Peter Doherty Institute for Infection and Immunity, WHO Collaborating Centre for Viral Hepatitis, Melbourne, AustraliaUlrich MüellerPhilipps-University Marburg, Marburg, GermanyDaniel KimDepartment of Health Sciences, Northeastern University, Boston, MassachusettsMatias TrilliniMario Negri Institute for pharmacological Research, Ranica, ItalyBabak EshratiArak University of Medical Sciences and Health Affairs, Arak, IranHywel C WilliamsUniversity of Nottingham, Nottingham, EnglandKenji ShibuyaUniversity of Tokyo, Tokyo, JapanRakhi DandonaPublic Health Foundation of India, National Capital Region, IndiaKinnari MurthyPublic Health Foundation of India, National Capital Region, IndiaBenjamin CowieVictorian Infectious Diseases Reference Laboratory (VIDRL), The Peter Doherty Institute for Infection and Immunity, WHO Collaborating Centre for Viral Hepatitis, Melbourne, AustraliaAzmeraw T. AmareDepartment of Epidemiology, University of Groningen, Groningen, the Netherlands

JAMA Oncologyjournal2015en

ABI

Аннотация

IMPORTANCE: Cancer is among the leading causes of death worldwide. Current estimates of cancer burden in individual countries and regions are necessary to inform local cancer control strategies. OBJECTIVE: To estimate mortality, incidence, years lived with disability (YLDs), years of life lost (YLLs), and disability-adjusted life-years (DALYs) for 28 cancers in 188 countries by sex from 1990 to 2013. EVIDENCE REVIEW: The general methodology of the Global Burden of Disease (GBD) 2013 study was used. Cancer registries were the source for cancer incidence data as well as mortality incidence (MI) ratios. Sources for cause of death data include vital registration system data, verbal autopsy studies, and other sources. The MI ratios were used to transform incidence data to mortality estimates and cause of death estimates to incidence estimates. Cancer prevalence was estimated using MI ratios as surrogates for survival data; YLDs were calculated by multiplying prevalence estimates with disability weights, which were derived from population-based surveys; YLLs were computed by multiplying the number of estimated cancer deaths at each age with a reference life expectancy; and DALYs were calculated as the sum of YLDs and YLLs. FINDINGS: In 2013 there were 14.9 million incident cancer cases, 8.2 million deaths, and 196.3 million DALYs. Prostate cancer was the leading cause for cancer incidence (1.4 million) for men and breast cancer for women (1.8 million). Tracheal, bronchus, and lung (TBL) cancer was the leading cause for cancer death in men and women, with 1.6 million deaths. For men, TBL cancer was the leading cause of DALYs (24.9 million). For women, breast cancer was the leading cause of DALYs (13.1 million). Age-standardized incidence rates (ASIRs) per 100 000 and age-standardized death rates (ASDRs) per 100 000 for both sexes in 2013 were higher in developing vs developed countries for stomach cancer (ASIR, 17 vs 14; ASDR, 15 vs 11), liver cancer (ASIR, 15 vs 7; ASDR, 16 vs 7), esophageal cancer (ASIR, 9 vs 4; ASDR, 9 vs 4), cervical cancer (ASIR, 8 vs 5; ASDR, 4 vs 2), lip and oral cavity cancer (ASIR, 7 vs 6; ASDR, 2 vs 2), and nasopharyngeal cancer (ASIR, 1.5 vs 0.4; ASDR, 1.2 vs 0.3). Between 1990 and 2013, ASIRs for all cancers combined (except nonmelanoma skin cancer and Kaposi sarcoma) increased by more than 10% in 113 countries and decreased by more than 10% in 12 of 188 countries. CONCLUSIONS AND RELEVANCE: Cancer poses a major threat to public health worldwide, and incidence rates have increased in most countries since 1990. The trend is a particular threat to developing nations with health systems that are ill-equipped to deal with complex and expensive cancer treatments. The annual update on the Global Burden of Cancer will provide all stakeholders with timely estimates to guide policy efforts in cancer prevention, screening, treatment, and palliation.

Перевод пока недоступен

Темы

Global Cancer Incidence and Screening Cancer Risks and Factors Multiple and Secondary Primary Cancers

Идентификаторы

DOI: 10.1001/jamaoncol.2015.0735

Цитирования и источники

Цитирований: 2Использованных источников: 0

Показатели — AkademScholar